Literature DB >> 34146197

ELF5 inhibits the proliferation and invasion of breast cancer cells by regulating CD24.

Xinjian Qu1, Qianqian Li2, Simei Tu2, Xiaocheng Yang2, Wen Wen2.   

Abstract

E74-like factor five (ELF5) is a basic transcription factor that plays a key role in breast tissue and gland development. However, the molecular mechanism of ELF5 in breast cancer cells has not been elucidated. In this study, we examined the effect of ELF5 on the human breast cancer cell lines MCF-7 and T47D and confirmed that ELF5 can inhibit cell proliferation, migration and invasion. In further research, the relationship between ELF5 and CD24 was characterized in breast cancer cells. We found that CD24 was a target gene of ELF5 through chromatin immunoprecipitation (ChIP) -Sequence assays, and proved that ELF5 could bind to the ETS cis-element on the proximal promoter of the CD24 gene and regulate the expression of CD24. Moreover, overexpression of ELF5 in MCF-7 cells significantly increased both the mRNA and protein levels of CD24, while knockdown of CD24 expression restored cell proliferation, migration and invasion through adaptive ELF5 expression in MCF-7 cells. Therefore, these data suggest that ELF5 inhibits migration and invasion of breast cancer cells by regulating CD24 expression, which make provides a molecular mechanism for ELF5 to inhibit breast cancer from a new perspective and provides further theoretical support for the treatment and prevention of breast cancer.
© 2021. The Author(s), under exclusive licence to Springer Nature B.V.

Entities:  

Keywords:  Breast cancer cells; CD24; ELF5; ETS; Tamoxifen resistance

Mesh:

Substances:

Year:  2021        PMID: 34146197     DOI: 10.1007/s11033-021-06495-7

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  39 in total

1.  Lineage specific methylation of the Elf5 promoter in mammary epithelial cells.

Authors:  Heather J Lee; Rebecca A Hinshelwood; Toula Bouras; David Gallego-Ortega; Fátima Valdés-Mora; Katrina Blazek; Jane E Visvader; Susan J Clark; Christopher J Ormandy
Journal:  Stem Cells       Date:  2011-10       Impact factor: 6.277

2.  Progesterone drives mammary secretory differentiation via RankL-mediated induction of Elf5 in luminal progenitor cells.

Authors:  Heather J Lee; David Gallego-Ortega; Anita Ledger; Daniel Schramek; Purna Joshi; Maria M Szwarc; Christina Cho; John P Lydon; Rama Khokha; Josef M Penninger; Christopher J Ormandy
Journal:  Development       Date:  2013-03-05       Impact factor: 6.868

Review 3.  Breast Cancer Stem Cells and Sex Steroid Hormones.

Authors:  Iván Flores-Ramírez; Noemi Baranda-Avila; Elizabeth Langley
Journal:  Curr Stem Cell Res Ther       Date:  2019       Impact factor: 3.828

Review 4.  Breast cancer stem cells: Biology and therapeutic implications.

Authors:  Ramesh Butti; Vinoth Prasanna Gunasekaran; Totakura V S Kumar; Pinaki Banerjee; Gopal C Kundu
Journal:  Int J Biochem Cell Biol       Date:  2018-12-05       Impact factor: 5.085

Review 5.  Elf5, hormones and cell fate.

Authors:  Heather J Lee; Christopher J Ormandy
Journal:  Trends Endocrinol Metab       Date:  2012-03-30       Impact factor: 12.015

6.  Elf5 regulates mammary gland stem/progenitor cell fate by influencing notch signaling.

Authors:  Rumela Chakrabarti; Yong Wei; Rose-Anne Romano; Christina DeCoste; Yibin Kang; Satrajit Sinha
Journal:  Stem Cells       Date:  2012-07       Impact factor: 6.277

7.  Socs2 and elf5 mediate prolactin-induced mammary gland development.

Authors:  Jessica Harris; Prudence M Stanford; Kate Sutherland; Samantha R Oakes; Matthew J Naylor; Fiona G Robertson; Katrina D Blazek; Michael Kazlauskas; Heidi N Hilton; Sergio Wittlin; Warren S Alexander; Geoffrey J Lindeman; Jane E Visvader; Christopher J Ormandy
Journal:  Mol Endocrinol       Date:  2006-02-09

8.  Breast cancer cells rely on environmental pyruvate to shape the metastatic niche.

Authors:  Matteo Rossi; Steve Stegen; Dorien Broekaert; Ginevra Doglioni; Marit van Gorsel; Ilaria Elia; Ruben Boon; Carmen Escalona-Noguero; Sophie Torrekens; Catherine Verfaillie; Erik Verbeken; Geert Carmeliet; Sarah-Maria Fendt
Journal:  Nature       Date:  2019-02-27       Impact factor: 49.962

9.  Elf5 - breast cancer's little helper.

Authors:  Hayley T Frend; Christine J Watson
Journal:  Breast Cancer Res       Date:  2013-03-27       Impact factor: 6.466

10.  Elf5 inhibits the epithelial-mesenchymal transition in mammary gland development and breast cancer metastasis by transcriptionally repressing Snail2.

Authors:  Rumela Chakrabarti; Julie Hwang; Mario Andres Blanco; Yong Wei; Martin Lukačišin; Rose-Anne Romano; Kirsten Smalley; Song Liu; Qifeng Yang; Toni Ibrahim; Laura Mercatali; Dino Amadori; Bruce G Haffty; Satrajit Sinha; Yibin Kang
Journal:  Nat Cell Biol       Date:  2012-10-21       Impact factor: 28.824

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.